The Effect of taVNS on the Prognosis of Patients Undergoing Pancreatoduodenectomy
Key facts
- Who runs it
- Affiliated Hospital of Nantong University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 84 people enrolled
- Started
- 17 Jan 2025
- Ended
- 31 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Transcutaneous Auricular Vagus Nerve Stimulator
- Record updated
- 1 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Age ≥18 years
- Diagnosed with pancreatic tumors or periampullary tumors by imaging or pathology and scheduled for pancreaticoduodenectomy
- No distant metastases and tumors are resectable
- Classified as American Society of Anesthesiologists (ASA) physical status I to III
- Capable of understanding the study procedures and various assessment scales and able to effectively communicate with the researchers
- Willing to participate in the study and provide written informed consent
Who cannot take part
- Patients who have undergone chemotherapy or radiotherapy before surgery
- Patients with implanted stimulators (e.g., pacemakers, implanted vagus nerve stimulators, deep brain stimulators, spinal cord stimulators), cochlear implants, or metallic implants (excluding dental work)
- Patients who recently used prokinetic agents, cholinergic or anticholinergic drugs, or hormones
- Patients who received vagus nerve stimulation or acupuncture within 1 month before the study
- Patients with other malignant tumors
- Patients with a history of gastrectomy or other gastric surgeries
- Patients diagnosed with chronic gastrointestinal inflammation, peptic ulcers, or a history of gastroparesis, pyloric, or other gastrointestinal obstructions
- Patients with a history of autonomic dysfunction (e.g., peripheral neuropathy, vagotomy, thyroid dysfunction, amyloidosis, asthma, heart failure, renal dysfunction, or alcoholism)
- Patients with skin damage or dermatological conditions at the stimulation site
- Patients with a preoperative heart rate below 60 beats per minute
- Patients with chronic organ dysfunction
- Patients unable to cooperate with assessments
- Patients participating in other clinical trials
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To explore the effects of transcutaneous auricular vagus nerve stimulation (taVNS) during the perioperative period on the incidence of delayed gastric emptying after pancreatoduodenectomy and its possible mechanisms.
The 2 groups in the trial
- Transcutaneous auricular vagus nerve stimulation (taVNS group)Treatment being tested
Patients in the taVNS group will have a transcutaneous auricular vagus nerve stimulation device with a transparent, non-insulated thin film placed on the cymba conchae of the left ear. TaVNS will be administered on the day of surgery (starting 30 minutes before anesthesia induction and continuing until the end of the surgery, terminating after the removal of the endotracheal tube in the PACU). The stimulation parameters are set as follows: frequency 25 Hz, pulse width 200 μs, 30 seconds on / 30 seconds off, with the current intensity set to the maximum amplitude the patient can tolerate (just below the pain threshold).
Treatment: Transcutaneous Auricular Vagus Nerve Stimulator
- Sham transcutaneous auricular vagus nerve stimulation (Sham taVNS group)No study treatment, for comparison
Patients in the Sham taVNS group will have a transcutaneous auricular vagus nerve stimulation device with a transparent insulating film placed on the cymba conchae of the left ear on the day of surgery. The stimulation parameters, method, and duration will be the same as those in the taVNS group. However, due to the insulating film applied to the stimulation device in the sham group, patients will not actually receive any stimulation.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on the Incidence of Delayed Gastric Emptying After Pancreatoduodenectomy: A Randomized Controlled Trial
- Record updated
- 1 September 2026